Amarin Corp Plcuk (AMRN) Operating Expenses (2010 - 2026)
Amarin Corp Plcuk (AMRN) posted quarterly Operating Expenses of $29.1 million for Q1 2026, down 30.52% YoY from $41.9 million in Q1 2025, and down 1.33% sequentially from $29.5 million in Q4 2025.
Amarin Corp Plcuk (AMRN) Operating Expenses (2010 - 2026) Analysis & Trends
Amarin Corp Plcuk has disclosed Operating Expenses across 17 years of filings, most recently posting $29.1 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 30.52% year-over-year to $29.1 million; the TTM figure through Mar 2026 stood at $158.3 million (down 6.68% YoY), while the FY2025 annual figure was $171.0 million, down 1.24% from the prior year.
- Operating Expenses slipped to $29.1 million in Q1 2026, from $29.5 million in the prior quarter.
- Over the last five years, Operating Expenses for AMRN reached as high as $106.5 million in Q2 2022 and fell as low as $29.1 million in Q1 2026.
- The 5-year median for Operating Expenses is $50.0 million (2023), against an average of $56.2 million.
- Annual changes were most pronounced in 2022 — Operating Expenses tumbled 45.55% — and 2025, when it jumped 53.25%.
- A 5-year view of Operating Expenses shows it stood at $73.2 million in 2022, then plunged by 31.74% to $50.0 million in 2023, then retreated by 14.02% to $43.0 million in 2024, then sank by 31.34% to $29.5 million in 2025, then fell by 1.33% to $29.1 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $29.1 million, $29.5 million, and $33.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 6.72 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 9.59 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 11.01 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -8.41 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 19.82 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 5.95 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 4.37 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 5.50 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Amarin Corp Plcuk | 5.17 Bn | 5.00 Bn | 17.77 Mn | 29.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.10 Mn |
| Dec 31, 2025 | 29.49 Mn |
| Sep 30, 2025 | 33.31 Mn |
| Jun 30, 2025 | 66.35 Mn |
| Mar 31, 2025 | 41.89 Mn |
| Dec 31, 2024 | 42.96 Mn |
| Sep 30, 2024 | 41.44 Mn |
| Jun 30, 2024 | 43.29 Mn |
| Mar 31, 2024 | 45.49 Mn |
| Dec 31, 2023 | 49.96 Mn |
| Sep 30, 2023 | 51.27 Mn |
| Jun 30, 2023 | 66.63 Mn |
| Mar 31, 2023 | 65.27 Mn |
| Dec 31, 2022 | 73.19 Mn |
| Sep 30, 2022 | 68.00 Mn |
| Jun 30, 2022 | 106.46 Mn |
| Mar 31, 2022 | 100.70 Mn |
| Dec 31, 2021 | 97.72 Mn |
| Sep 30, 2021 | 124.90 Mn |
| Jun 30, 2021 | 113.56 Mn |